
Pediatric dysphonia: It’s not about the nodules.
Authors of this article are:
Dohar JE, Shaffer AD, White KE.
A summary of the article is shown below:
OBJECTIVE: Despite the fact that vocal nodules are the most common cause of chronic dysphonia in children, uncertainty and lack of consensus complicates practically every diagnostic and management decision. Selecting an optimal staging system is fundamental to understanding a disease process, mandatory for uniform reporting, and crucial to predicting natural history and treatment outcomes. The ideal prognostic model for vocal nodules is under intense debate. The purpose of this study was to analyze the predictive power of vocal nodule grade to severity of voice metrics in children.METHODS: Seventy-nine patients diagnosed with vocal cord nodules between 2006 and 2012 were drawn from UPMC Children’s Hospital of Pittsburgh Voice, Resonance and Swallowing Center Research Registry. Subject age at time of diagnosis, nodule grade, relevant co-morbidities, scores on The Consensus Auditory-Perceptual Evaluation of Voice (CAPE-V), parent-reported Pediatric Voice Handicap Index (pVHI), the phonotraumatic behaviors profile, habitual speaking pitch fundamental frequencies, pitch range, volume intensity, and s/z ratio were recorded and compiled into a de-identified database for analysis.RESULTS: Based on the Kruskal-Wallis H Test, there was no statistically significant correlation between nodule grade and total pitch range (p = .21), s/z ratio (p = .50), volume intensity (p = .33), overall CAPE-V Scores (p = .15), or pVHI Scores (p = .29). Chi-squared tests also revealed no significant associations between nodule grade and abnormality in habitual speaking pitch (p = .14 for fundamental frequency while sustaining a vowel sound, p = .37 for fundamental frequency while speaking structured tasks i.e. counting, or p = .76 while speaking in conversation).CONCLUSION: The current “gold-standard” for grading vocal nodule size suggests that the nodules themselves are not driving the standard dysphonic metrics that are most commonly collected and monitored in such children. This outcome is consistent with other studies reporting similar findings and was expected based on the inconsistencies in the reported literature to date. By extension, the conventional wisdom of avoiding surgical treatment of vocal nodules in children seems prudent as there is little evidence to suggest that the nodules themselves are “driving” the severity of the dysphonia. Ultimately identifying the true “drivers” of dysphonia in children will suggest alternative therapies that are more specific and directed to the pathophysiology. Most pediatric voice care professionals will welcome such discoveries as those in the front line of patient care are often rendered helpless and frustrated.Copyright © 2019 Elsevier B.V. All rights reserved.
Check out the article’s website on Pubmed for more information:
This article is a good source of information and a good way to become familiar with topics such as: Children;Dysphonia;Vocal nodules.
New Chemicals from MOLECULAR DEPOT
-
Microparticle Activation Buffer
Sale!$495.00$195.00 -
Triglyceride Mix for Interference Testing
Sale!$495.00$295.00 -
Tacrolimus Biotin Conjugate
Sale!$875.00$550.00 -
Microparticle Blocking Buffer
Sale!$695.00$250.00 -
Microparticle Anti Aggregation Agent
Sale!$495.00$195.00 -
Progesterone Biotin Conjugate
Sale!$495.00$195.00 -
Latex Microparticle Stabilizer
From: $95.00 -
Tacrolimus Biotin Conjugate (PEG11 Spacer)
Sale!$795.00$495.00 -
Microparticle Washing Buffer
Sale!$495.00$195.00 -
CPRG (Chlorophenol red-β-D-galactopyranoside)
From: $150.00
New Proteins from MOLECULAR DEPOT
-
NT-proBNP Protein Recombinant
Sale!$775.00$475.00 -
Tacrolimus BSA Conjugate
Sale!$695.00$475.00 -
Recombinant Human Serum Amyloid A1 (SAA)
Sale!$395.00$195.00 -
Cystatin C Protein Recombinant
Sale!$395.00$195.00 -
Horseradish Peroxidase Biotinylated
Sale!$295.00$175.00 -
Creatinine BSA Conjugate
Sale!$995.00$595.00 -
Human Fibrinogen
Sale!$295.00$150.00 -
Hyaluronic Acid Binding Protein
Sale!$475.00$250.00 -
Biotinylated Tacrolimus BSA Conjugate
Sale!$995.00$675.00 -
25-OH Vitamin D BSA Conjugate
Sale!$795.00$450.00
New Antibodies from MOLECULAR DEPOT
-
Phenytoin Antibody
From: $350.00 -
Human Myoglobin Antibody
Sale!$450.00$195.00 -
Anti Human IgA Antibody
Sale!$450.00$195.00 -
Alpha-Fetoprotein Monoclonal Antibodies
From: $495.00 -
SAA Antibody Polyclonal
Sale!$395.00$175.00 -
Antibody to FSH
Sale!$450.00$195.00 -
Rheumatoid Factor Interference Blocker
Sale!$595.00$395.00 -
Beta Galactosidase Antibody
Sale!$425.00$250.00 -
MPO Antibody Monoclonal
Sale!$495.00$195.00 -
Cystatin C Antibody Monoclonal
Sale!$375.00$195.00
New Research Kits from MOLECULAR DEPOT